ID   MUTYH_HUMAN             Reviewed;         546 AA.
AC   Q9UIF7; D3DPZ4; Q15830; Q9UBP2; Q9UBS7; Q9UIF4; Q9UIF5; Q9UIF6;
DT   07-JUN-2004, integrated into UniProtKB/Swiss-Prot.
DT   01-MAY-2000, sequence version 1.
DT   04-FEB-2015, entry version 142.
DE   RecName: Full=A/G-specific adenine DNA glycosylase;
DE            EC=3.2.2.-;
DE   AltName: Full=MutY homolog;
DE            Short=hMYH;
GN   Name=MUTYH; Synonyms=MYH;
OS   Homo sapiens (Human).
OC   Eukaryota; Metazoa; Chordata; Craniata; Vertebrata; Euteleostomi;
OC   Mammalia; Eutheria; Euarchontoglires; Primates; Haplorrhini;
OC   Catarrhini; Hominidae; Homo.
OX   NCBI_TaxID=9606;
RN   [1]
RP   NUCLEOTIDE SEQUENCE [GENOMIC DNA] (ISOFORM ALPHA-3).
RX   PubMed=8682794;
RA   Slupska M.M., Baikalov C., Luther W.M., Chiang J.H., Wei Y.F.,
RA   Miller J.H.;
RT   "Cloning and sequencing a human homolog (hMYH) of the Escherichia coli
RT   mutY gene whose function is required for the repair of oxidative DNA
RT   damage.";
RL   J. Bacteriol. 178:3885-3892(1996).
RN   [2]
RP   NUCLEOTIDE SEQUENCE [MRNA] (ISOFORMS ALPHA-1; ALPHA-2; ALPHA-3;
RP   BETA-1; GAMMA-2 AND GAMMA-3), AND FUNCTION.
RX   PubMed=10684930; DOI=10.1093/nar/28.6.1355;
RA   Ohtsubo T., Nishioka K., Imaiso Y., Iwai S., Shimokawa H., Oda H.,
RA   Fujikawa T., Nakabeppu Y.;
RT   "Identification of human MutY homolog (hMYH) as a repair enzyme for 2-
RT   hydroxyadenine in DNA and detection of multiple forms of hMYH located
RT   in nuclei and mitochondria.";
RL   Nucleic Acids Res. 28:1355-1364(2000).
RN   [3]
RP   NUCLEOTIDE SEQUENCE [GENOMIC DNA].
RX   PubMed=20843780; DOI=10.1093/nar/gkq750;
RA   Wang W., Shen P., Thiyagarajan S., Lin S., Palm C., Horvath R.,
RA   Klopstock T., Cutler D., Pique L., Schrijver I., Davis R.W.,
RA   Mindrinos M., Speed T.P., Scharfe C.;
RT   "Identification of rare DNA variants in mitochondrial disorders with
RT   improved array-based sequencing.";
RL   Nucleic Acids Res. 39:44-58(2011).
RN   [4]
RP   NUCLEOTIDE SEQUENCE [GENOMIC DNA], AND VARIANTS MET-22; HIS-335;
RP   GLU-500; MET-526 AND GLN-531.
RG   NIEHS SNPs program;
RL   Submitted (JUL-2002) to the EMBL/GenBank/DDBJ databases.
RN   [5]
RP   NUCLEOTIDE SEQUENCE [LARGE SCALE GENOMIC DNA].
RX   PubMed=16710414; DOI=10.1038/nature04727;
RA   Gregory S.G., Barlow K.F., McLay K.E., Kaul R., Swarbreck D.,
RA   Dunham A., Scott C.E., Howe K.L., Woodfine K., Spencer C.C.A.,
RA   Jones M.C., Gillson C., Searle S., Zhou Y., Kokocinski F.,
RA   McDonald L., Evans R., Phillips K., Atkinson A., Cooper R., Jones C.,
RA   Hall R.E., Andrews T.D., Lloyd C., Ainscough R., Almeida J.P.,
RA   Ambrose K.D., Anderson F., Andrew R.W., Ashwell R.I.S., Aubin K.,
RA   Babbage A.K., Bagguley C.L., Bailey J., Beasley H., Bethel G.,
RA   Bird C.P., Bray-Allen S., Brown J.Y., Brown A.J., Buckley D.,
RA   Burton J., Bye J., Carder C., Chapman J.C., Clark S.Y., Clarke G.,
RA   Clee C., Cobley V., Collier R.E., Corby N., Coville G.J., Davies J.,
RA   Deadman R., Dunn M., Earthrowl M., Ellington A.G., Errington H.,
RA   Frankish A., Frankland J., French L., Garner P., Garnett J., Gay L.,
RA   Ghori M.R.J., Gibson R., Gilby L.M., Gillett W., Glithero R.J.,
RA   Grafham D.V., Griffiths C., Griffiths-Jones S., Grocock R.,
RA   Hammond S., Harrison E.S.I., Hart E., Haugen E., Heath P.D.,
RA   Holmes S., Holt K., Howden P.J., Hunt A.R., Hunt S.E., Hunter G.,
RA   Isherwood J., James R., Johnson C., Johnson D., Joy A., Kay M.,
RA   Kershaw J.K., Kibukawa M., Kimberley A.M., King A., Knights A.J.,
RA   Lad H., Laird G., Lawlor S., Leongamornlert D.A., Lloyd D.M.,
RA   Loveland J., Lovell J., Lush M.J., Lyne R., Martin S.,
RA   Mashreghi-Mohammadi M., Matthews L., Matthews N.S.W., McLaren S.,
RA   Milne S., Mistry S., Moore M.J.F., Nickerson T., O'Dell C.N.,
RA   Oliver K., Palmeiri A., Palmer S.A., Parker A., Patel D., Pearce A.V.,
RA   Peck A.I., Pelan S., Phelps K., Phillimore B.J., Plumb R., Rajan J.,
RA   Raymond C., Rouse G., Saenphimmachak C., Sehra H.K., Sheridan E.,
RA   Shownkeen R., Sims S., Skuce C.D., Smith M., Steward C.,
RA   Subramanian S., Sycamore N., Tracey A., Tromans A., Van Helmond Z.,
RA   Wall M., Wallis J.M., White S., Whitehead S.L., Wilkinson J.E.,
RA   Willey D.L., Williams H., Wilming L., Wray P.W., Wu Z., Coulson A.,
RA   Vaudin M., Sulston J.E., Durbin R.M., Hubbard T., Wooster R.,
RA   Dunham I., Carter N.P., McVean G., Ross M.T., Harrow J., Olson M.V.,
RA   Beck S., Rogers J., Bentley D.R.;
RT   "The DNA sequence and biological annotation of human chromosome 1.";
RL   Nature 441:315-321(2006).
RN   [6]
RP   NUCLEOTIDE SEQUENCE [LARGE SCALE GENOMIC DNA].
RA   Mural R.J., Istrail S., Sutton G.G., Florea L., Halpern A.L.,
RA   Mobarry C.M., Lippert R., Walenz B., Shatkay H., Dew I., Miller J.R.,
RA   Flanigan M.J., Edwards N.J., Bolanos R., Fasulo D., Halldorsson B.V.,
RA   Hannenhalli S., Turner R., Yooseph S., Lu F., Nusskern D.R.,
RA   Shue B.C., Zheng X.H., Zhong F., Delcher A.L., Huson D.H.,
RA   Kravitz S.A., Mouchard L., Reinert K., Remington K.A., Clark A.G.,
RA   Waterman M.S., Eichler E.E., Adams M.D., Hunkapiller M.W., Myers E.W.,
RA   Venter J.C.;
RL   Submitted (SEP-2005) to the EMBL/GenBank/DDBJ databases.
RN   [7]
RP   NUCLEOTIDE SEQUENCE [LARGE SCALE MRNA] (ISOFORM ALPHA-3).
RC   TISSUE=Kidney;
RX   PubMed=15489334; DOI=10.1101/gr.2596504;
RG   The MGC Project Team;
RT   "The status, quality, and expansion of the NIH full-length cDNA
RT   project: the Mammalian Gene Collection (MGC).";
RL   Genome Res. 14:2121-2127(2004).
RN   [8]
RP   STRUCTURE BY NMR OF 356-497.
RG   RIKEN structural genomics initiative (RSGI);
RT   "Solution structure of the NUDIX domain from human A/G-specific
RT   adenine DNA glycosylase alpha-3 splice isoform.";
RL   Submitted (NOV-2005) to the PDB data bank.
RN   [9]
RP   VARIANTS FAP2 CYS-176 AND ASP-393.
RX   PubMed=11818965; DOI=10.1038/ng828;
RA   Al-Tassan N., Chmiel N.H., Maynard J., Fleming N., Livingston A.L.,
RA   Williams G.T., Hodges A.K., Davies D.R., David S.S., Sampson J.R.,
RA   Cheadle J.P.;
RT   "Inherited variants of MYH associated with somatic G:C-->T:A mutations
RT   in colorectal tumors.";
RL   Nat. Genet. 30:227-232(2002).
RN   [10]
RP   VARIANTS FAP2 ARG-128; CYS-176 AND ASP-393.
RX   PubMed=12853198; DOI=10.1016/S0140-6736(03)13805-6;
RA   Sampson J.R., Dolwani S., Jones S., Eccles D., Ellis A., Evans D.G.,
RA   Frayling I., Jordan S., Maher E.R., Mak T., Maynard J., Pigatto F.,
RA   Shaw J., Cheadle J.P.;
RT   "Autosomal recessive colorectal adenomatous polyposis due to inherited
RT   mutations of MYH.";
RL   Lancet 362:39-41(2003).
RN   [11]
RP   VARIANTS FAP2 CYS-176 AND ASP-393, AND VARIANTS MET-22; HIS-335 AND
RP   PHE-512.
RX   PubMed=12606733; DOI=10.1056/NEJMoa025283;
RA   Sieber O.M., Lipton L., Crabtree M., Heinimann K., Fidalgo P.,
RA   Phillips R.K.S., Bisgaard M.-L., Orntoft T.F., Aaltonen L.A.,
RA   Hodgson S.V., Thomas H.J.W., Tomlinson I.P.M.;
RT   "Multiple colorectal adenomas, classic adenomatous polyposis, and
RT   germ-line mutations in MYH.";
RL   N. Engl. J. Med. 348:791-799(2003).
RN   [12]
RP   VARIANTS FAP2 HIS-125; HIS-179 AND TRP-238.
RX   PubMed=15366000; DOI=10.1002/humu.9282;
RA   Isidro G., Laranjeira F., Pires A., Leite J., Regateiro F.,
RA   Castro e Sousa F., Soares J., Castro C., Giria J., Brito M.J.,
RA   Medeira A., Teixeira R., Morna H., Gaspar I., Marinho C., Jorge R.,
RA   Brehm A., Ramos J.S., Boavida M.G.;
RT   "Germline MUTYH (MYH) mutations in Portuguese individuals with
RT   multiple colorectal adenomas.";
RL   Hum. Mutat. 24:353-354(2004).
RN   [13]
RP   VARIANTS GASC SER-402 AND ARG-411.
RX   PubMed=15273732; DOI=10.1038/sj.onc.1207574;
RA   Kim C.J., Cho Y.G., Park C.H., Kim S.Y., Nam S.W., Lee S.H., Yoo N.J.,
RA   Lee J.Y., Park W.S.;
RT   "Genetic alterations of the MYH gene in gastric cancer.";
RL   Oncogene 23:6820-6822(2004).
RN   [14]
RP   VARIANTS FAP2 CYS-176; CYS-179; TRP-182 AND ASP-393.
RX   PubMed=18091433; DOI=10.1097/GIM.0b013e31815bf940;
RA   Cattaneo F., Molatore S., Mihalatos M., Apessos A., Venesio T.,
RA   Bione S., Grignani P., Nasioulas G., Ranzani G.N.;
RT   "Heterogeneous molecular mechanisms underlie attenuated familial
RT   adenomatous polyposis.";
RL   Genet. Med. 9:836-841(2007).
RN   [15]
RP   VARIANTS FAP2 148-GLY ILE-TRP DELINS; TRP-182 AND 477-GLU DEL, AND
RP   CHARACTERIZATION OF VARIANTS FAP2 148-GLY ILE-TRP DELINS; CYS-176;
RP   TRP-182; ASP-393 AND 477-GLU DEL.
RX   PubMed=19953527; DOI=10.1002/humu.21158;
RA   Molatore S., Russo M.T., D'Agostino V.G., Barone F., Matsumoto Y.,
RA   Albertini A.M., Minoprio A., Degan P., Mazzei F., Bignami M.,
RA   Ranzani G.N.;
RT   "MUTYH mutations associated with familial adenomatous polyposis:
RT   functional characterization by a mammalian cell-based assay.";
RL   Hum. Mutat. 31:159-166(2010).
CC   -!- FUNCTION: Involved in oxidative DNA damage repair. Initiates
CC       repair of A*oxoG to C*G by removing the inappropriately paired
CC       adenine base from the DNA backbone. Possesses both adenine and 2-
CC       OH-A DNA glycosylase activities. {ECO:0000269|PubMed:10684930}.
CC   -!- COFACTOR:
CC       Name=[4Fe-4S] cluster; Xref=ChEBI:CHEBI:49883;
CC         Evidence={ECO:0000250};
CC       Note=Binds 1 [4Fe-4S] cluster. The cluster does not appear to play
CC       a role in catalysis, but is probably involved in the proper
CC       positioning of the enzyme along the DNA strand. {ECO:0000250};
CC   -!- SUBCELLULAR LOCATION: Nucleus.
CC   -!- ALTERNATIVE PRODUCTS:
CC       Event=Alternative splicing; Named isoforms=6;
CC       Name=Alpha-1;
CC         IsoId=Q9UIF7-1; Sequence=Displayed;
CC       Name=Alpha-2;
CC         IsoId=Q9UIF7-2; Sequence=VSP_010549;
CC       Name=Alpha-3;
CC         IsoId=Q9UIF7-3; Sequence=VSP_010550;
CC       Name=Beta-1;
CC         IsoId=Q9UIF7-4; Sequence=VSP_010548;
CC       Name=Gamma-2;
CC         IsoId=Q9UIF7-5; Sequence=VSP_010548, VSP_010549;
CC       Name=Gamma-3;
CC         IsoId=Q9UIF7-6; Sequence=VSP_010548, VSP_010550;
CC   -!- DISEASE: Familial adenomatous polyposis 2 (FAP2) [MIM:608456]: A
CC       condition characterized by the development of multiple colorectal
CC       adenomatous polyps, benign neoplasms derived from glandular
CC       epithelium. Some affected individuals may develop colorectal
CC       carcinoma. {ECO:0000269|PubMed:11818965,
CC       ECO:0000269|PubMed:12606733, ECO:0000269|PubMed:12853198,
CC       ECO:0000269|PubMed:15366000, ECO:0000269|PubMed:18091433,
CC       ECO:0000269|PubMed:19953527}. Note=The disease is caused by
CC       mutations affecting the gene represented in this entry.
CC   -!- DISEASE: Gastric cancer (GASC) [MIM:613659]: A malignant disease
CC       which starts in the stomach, can spread to the esophagus or the
CC       small intestine, and can extend through the stomach wall to nearby
CC       lymph nodes and organs. It also can metastasize to other parts of
CC       the body. The term gastric cancer or gastric carcinoma refers to
CC       adenocarcinoma of the stomach that accounts for most of all
CC       gastric malignant tumors. Two main histologic types are
CC       recognized, diffuse type and intestinal type carcinomas. Diffuse
CC       tumors are poorly differentiated infiltrating lesions, resulting
CC       in thickening of the stomach. In contrast, intestinal tumors are
CC       usually exophytic, often ulcerating, and associated with
CC       intestinal metaplasia of the stomach, most often observed in
CC       sporadic disease. {ECO:0000269|PubMed:15273732}. Note=The gene
CC       represented in this entry may be involved in disease pathogenesis.
CC       Somatic mutations contribute to the development of a sub-set of
CC       sporadic gastric cancers in carriers of Helicobacter pylori
CC       (PubMed:15273732). {ECO:0000269|PubMed:15273732}.
CC   -!- SIMILARITY: Belongs to the Nth/MutY family. {ECO:0000305}.
CC   -!- SIMILARITY: Contains 1 nudix hydrolase domain.
CC       {ECO:0000255|PROSITE-ProRule:PRU00794}.
CC   -!- SEQUENCE CAUTION:
CC       Sequence=BAA89339.1; Type=Erroneous initiation; Note=Translation N-terminally extended.; Evidence={ECO:0000305};
CC       Sequence=BAA89339.1; Type=Miscellaneous discrepancy; Note=Probable cloning artifact.; Evidence={ECO:0000305};
CC       Sequence=BAA89345.1; Type=Erroneous initiation; Note=Translation N-terminally extended.; Evidence={ECO:0000305};
CC       Sequence=BAA89345.1; Type=Miscellaneous discrepancy; Note=Probable cloning artifact.; Evidence={ECO:0000305};
CC   -!- WEB RESOURCE: Name=Atlas of Genetics and Cytogenetics in Oncology
CC       and Haematology;
CC       URL="http://atlasgeneticsoncology.org/Genes/MUTYHID41464ch1p34.html";
CC   -!- WEB RESOURCE: Name=NIEHS-SNPs;
CC       URL="http://egp.gs.washington.edu/data/mutyh/";
CC   -----------------------------------------------------------------------
CC   Copyrighted by the UniProt Consortium, see http://www.uniprot.org/terms
CC   Distributed under the Creative Commons Attribution-NoDerivs License
CC   -----------------------------------------------------------------------
DR   EMBL; U63329; AAC50618.1; -; Genomic_DNA.
DR   EMBL; AB032920; BAA89336.1; -; mRNA.
DR   EMBL; AB032921; BAA89337.1; -; mRNA.
DR   EMBL; AB032922; BAA89338.1; -; mRNA.
DR   EMBL; AB032923; BAA89339.1; ALT_SEQ; mRNA.
DR   EMBL; AB032924; BAA89340.1; -; mRNA.
DR   EMBL; AB032925; BAA89341.1; -; mRNA.
DR   EMBL; AB032926; BAA89342.1; -; mRNA.
DR   EMBL; AB032927; BAA89343.1; -; mRNA.
DR   EMBL; AB032928; BAA89344.1; -; mRNA.
DR   EMBL; AB032929; BAA89345.1; ALT_SEQ; mRNA.
DR   EMBL; HQ205466; ADP90937.1; -; Genomic_DNA.
DR   EMBL; HQ205468; ADP90947.1; -; Genomic_DNA.
DR   EMBL; HQ205469; ADP90952.1; -; Genomic_DNA.
DR   EMBL; HQ205470; ADP90957.1; -; Genomic_DNA.
DR   EMBL; HQ205472; ADP90967.1; -; Genomic_DNA.
DR   EMBL; HQ205473; ADP90972.1; -; Genomic_DNA.
DR   EMBL; HQ205474; ADP90977.1; -; Genomic_DNA.
DR   EMBL; HQ205475; ADP90982.1; -; Genomic_DNA.
DR   EMBL; HQ205476; ADP90987.1; -; Genomic_DNA.
DR   EMBL; HQ205477; ADP90992.1; -; Genomic_DNA.
DR   EMBL; HQ205479; ADP91002.1; -; Genomic_DNA.
DR   EMBL; HQ205480; ADP91007.1; -; Genomic_DNA.
DR   EMBL; HQ205481; ADP91012.1; -; Genomic_DNA.
DR   EMBL; HQ205482; ADP91017.1; -; Genomic_DNA.
DR   EMBL; HQ205483; ADP91022.1; -; Genomic_DNA.
DR   EMBL; HQ205484; ADP91027.1; -; Genomic_DNA.
DR   EMBL; HQ205485; ADP91032.1; -; Genomic_DNA.
DR   EMBL; HQ205486; ADP91037.1; -; Genomic_DNA.
DR   EMBL; HQ205487; ADP91042.1; -; Genomic_DNA.
DR   EMBL; HQ205488; ADP91047.1; -; Genomic_DNA.
DR   EMBL; HQ205489; ADP91052.1; -; Genomic_DNA.
DR   EMBL; HQ205490; ADP91057.1; -; Genomic_DNA.
DR   EMBL; HQ205491; ADP91062.1; -; Genomic_DNA.
DR   EMBL; HQ205492; ADP91067.1; -; Genomic_DNA.
DR   EMBL; HQ205493; ADP91072.1; -; Genomic_DNA.
DR   EMBL; HQ205494; ADP91077.1; -; Genomic_DNA.
DR   EMBL; HQ205495; ADP91082.1; -; Genomic_DNA.
DR   EMBL; HQ205496; ADP91087.1; -; Genomic_DNA.
DR   EMBL; HQ205497; ADP91092.1; -; Genomic_DNA.
DR   EMBL; HQ205498; ADP91097.1; -; Genomic_DNA.
DR   EMBL; HQ205499; ADP91102.1; -; Genomic_DNA.
DR   EMBL; HQ205500; ADP91107.1; -; Genomic_DNA.
DR   EMBL; HQ205501; ADP91112.1; -; Genomic_DNA.
DR   EMBL; HQ205502; ADP91117.1; -; Genomic_DNA.
DR   EMBL; HQ205503; ADP91122.1; -; Genomic_DNA.
DR   EMBL; HQ205505; ADP91132.1; -; Genomic_DNA.
DR   EMBL; AF527839; AAM78555.1; -; Genomic_DNA.
DR   EMBL; AL359540; CAI21713.1; -; Genomic_DNA.
DR   EMBL; AL359540; CAI21714.1; -; Genomic_DNA.
DR   EMBL; AL359540; CAI21718.1; -; Genomic_DNA.
DR   EMBL; AL359540; CAI21719.1; -; Genomic_DNA.
DR   EMBL; AL359540; CAI21720.1; -; Genomic_DNA.
DR   EMBL; CH471059; EAX06993.1; -; Genomic_DNA.
DR   EMBL; CH471059; EAX06996.1; -; Genomic_DNA.
DR   EMBL; CH471059; EAX06997.1; -; Genomic_DNA.
DR   EMBL; BC003178; AAH03178.1; -; mRNA.
DR   CCDS; CCDS41320.1; -. [Q9UIF7-3]
DR   CCDS; CCDS41321.1; -. [Q9UIF7-5]
DR   CCDS; CCDS41322.1; -. [Q9UIF7-6]
DR   CCDS; CCDS520.1; -. [Q9UIF7-1]
DR   CCDS; CCDS72776.1; -. [Q9UIF7-4]
DR   CCDS; CCDS72777.1; -. [Q9UIF7-2]
DR   RefSeq; NP_001041636.1; NM_001048171.1. [Q9UIF7-3]
DR   RefSeq; NP_001041637.1; NM_001048172.1. [Q9UIF7-5]
DR   RefSeq; NP_001041638.1; NM_001048173.1. [Q9UIF7-6]
DR   RefSeq; NP_001041639.1; NM_001048174.1. [Q9UIF7-6]
DR   RefSeq; NP_001121897.1; NM_001128425.1.
DR   RefSeq; NP_001280119.1; NM_001293190.1. [Q9UIF7-2]
DR   RefSeq; NP_001280120.1; NM_001293191.1. [Q9UIF7-4]
DR   RefSeq; NP_001280121.1; NM_001293192.1.
DR   RefSeq; NP_001280124.1; NM_001293195.1. [Q9UIF7-6]
DR   RefSeq; NP_001280125.1; NM_001293196.1.
DR   RefSeq; NP_036354.1; NM_012222.2. [Q9UIF7-1]
DR   RefSeq; XP_006710711.1; XM_006710648.1. [Q9UIF7-4]
DR   UniGene; Hs.271353; -.
DR   PDB; 1X51; NMR; -; A=356-497.
DR   PDB; 3N5N; X-ray; 2.30 A; X/Y=76-362.
DR   PDBsum; 1X51; -.
DR   PDBsum; 3N5N; -.
DR   ProteinModelPortal; Q9UIF7; -.
DR   SMR; Q9UIF7; 79-497.
DR   BioGrid; 110681; 9.
DR   DIP; DIP-41972N; -.
DR   IntAct; Q9UIF7; 1.
DR   MINT; MINT-151684; -.
DR   STRING; 9606.ENSP00000408176; -.
DR   PhosphoSite; Q9UIF7; -.
DR   DMDM; 48428272; -.
DR   MaxQB; Q9UIF7; -.
DR   PaxDb; Q9UIF7; -.
DR   PRIDE; Q9UIF7; -.
DR   Ensembl; ENST00000354383; ENSP00000346354; ENSG00000132781. [Q9UIF7-5]
DR   Ensembl; ENST00000355498; ENSP00000347685; ENSG00000132781. [Q9UIF7-6]
DR   Ensembl; ENST00000372098; ENSP00000361170; ENSG00000132781. [Q9UIF7-1]
DR   Ensembl; ENST00000372104; ENSP00000361176; ENSG00000132781. [Q9UIF7-6]
DR   Ensembl; ENST00000372110; ENSP00000361182; ENSG00000132781. [Q9UIF7-2]
DR   Ensembl; ENST00000372115; ENSP00000361187; ENSG00000132781. [Q9UIF7-3]
DR   Ensembl; ENST00000448481; ENSP00000409718; ENSG00000132781. [Q9UIF7-4]
DR   Ensembl; ENST00000456914; ENSP00000407590; ENSG00000132781. [Q9UIF7-6]
DR   GeneID; 4595; -.
DR   KEGG; hsa:4595; -.
DR   UCSC; uc001cnf.3; human. [Q9UIF7-6]
DR   UCSC; uc001cng.3; human. [Q9UIF7-1]
DR   UCSC; uc001cnn.3; human. [Q9UIF7-2]
DR   CTD; 4595; -.
DR   GeneCards; GC01M045794; -.
DR   GeneReviews; MUTYH; -.
DR   HGNC; HGNC:7527; MUTYH.
DR   HPA; HPA008732; -.
DR   MIM; 604933; gene.
DR   MIM; 608456; phenotype.
DR   MIM; 613659; phenotype.
DR   neXtProt; NX_Q9UIF7; -.
DR   Orphanet; 26106; Familial gastric cancer.
DR   Orphanet; 247798; MUTYH-related attenuated familial adenomatous polyposis.
DR   PharmGKB; PA31328; -.
DR   eggNOG; COG1194; -.
DR   GeneTree; ENSGT00510000047220; -.
DR   HOVERGEN; HBG052540; -.
DR   InParanoid; Q9UIF7; -.
DR   KO; K03575; -.
DR   PhylomeDB; Q9UIF7; -.
DR   TreeFam; TF328549; -.
DR   Reactome; REACT_1064; Displacement of DNA glycosylase by APE1.
DR   Reactome; REACT_1729; Cleavage of the damaged purine.
DR   Reactome; REACT_2176; Recognition and association of DNA glycosylase with site containing an affected purine.
DR   EvolutionaryTrace; Q9UIF7; -.
DR   GeneWiki; MUTYH; -.
DR   GenomeRNAi; 4595; -.
DR   NextBio; 17664; -.
DR   PRO; PR:Q9UIF7; -.
DR   Proteomes; UP000005640; Chromosome 1.
DR   Bgee; Q9UIF7; -.
DR   CleanEx; HS_MUTYH; -.
DR   ExpressionAtlas; Q9UIF7; baseline and differential.
DR   Genevestigator; Q9UIF7; -.
DR   GO; GO:0005739; C:mitochondrion; IEA:Ensembl.
DR   GO; GO:0005654; C:nucleoplasm; TAS:Reactome.
DR   GO; GO:0005634; C:nucleus; IDA:HPA.
DR   GO; GO:0051539; F:4 iron, 4 sulfur cluster binding; IEA:UniProtKB-KW.
DR   GO; GO:0016798; F:hydrolase activity, acting on glycosyl bonds; IEA:UniProtKB-KW.
DR   GO; GO:0046872; F:metal ion binding; IEA:UniProtKB-KW.
DR   GO; GO:0032407; F:MutSalpha complex binding; IDA:HGNC.
DR   GO; GO:0006284; P:base-excision repair; TAS:Reactome.
DR   GO; GO:0006285; P:base-excision repair, AP site formation; TAS:Reactome.
DR   GO; GO:0045007; P:depurination; TAS:Reactome.
DR   GO; GO:0006281; P:DNA repair; TAS:Reactome.
DR   GO; GO:0006298; P:mismatch repair; TAS:ProtInc.
DR   Gene3D; 1.10.1670.10; -; 1.
DR   Gene3D; 1.10.340.30; -; 1.
DR   Gene3D; 3.90.79.10; -; 1.
DR   InterPro; IPR011257; DNA_glycosylase.
DR   InterPro; IPR004036; Endonuclease-III-like_CS2.
DR   InterPro; IPR004035; Endouclease-III_FeS-bd_BS.
DR   InterPro; IPR003651; Endouclease3_FeS-loop_motif.
DR   InterPro; IPR003265; HhH-GPD_domain.
DR   InterPro; IPR023170; HTH_base_excis_C.
DR   InterPro; IPR029119; MutY_C.
DR   InterPro; IPR000086; NUDIX_hydrolase_dom.
DR   InterPro; IPR015797; NUDIX_hydrolase_dom-like.
DR   Pfam; PF00730; HhH-GPD; 1.
DR   Pfam; PF14815; NUDIX_4; 1.
DR   SMART; SM00478; ENDO3c; 1.
DR   SMART; SM00525; FES; 1.
DR   SUPFAM; SSF48150; SSF48150; 1.
DR   SUPFAM; SSF55811; SSF55811; 1.
DR   PROSITE; PS00764; ENDONUCLEASE_III_1; 1.
DR   PROSITE; PS01155; ENDONUCLEASE_III_2; 1.
DR   PROSITE; PS51462; NUDIX; 1.
PE   1: Evidence at protein level;
KW   3D-structure; 4Fe-4S; Alternative splicing; Complete proteome;
KW   Disease mutation; DNA damage; DNA repair; Glycosidase; Hydrolase;
KW   Iron; Iron-sulfur; Metal-binding; Nucleus; Polymorphism;
KW   Reference proteome; Tumor suppressor.
FT   CHAIN         1    546       A/G-specific adenine DNA glycosylase.
FT                                /FTId=PRO_0000102239.
FT   DOMAIN      364    495       Nudix hydrolase. {ECO:0000255|PROSITE-
FT                                ProRule:PRU00794}.
FT   MOTIF       404    426       Nudix box.
FT   METAL       287    287       Iron-sulfur (4Fe-4S). {ECO:0000250}.
FT   METAL       294    294       Iron-sulfur (4Fe-4S). {ECO:0000250}.
FT   METAL       297    297       Iron-sulfur (4Fe-4S). {ECO:0000250}.
FT   METAL       303    303       Iron-sulfur (4Fe-4S). {ECO:0000250}.
FT   VAR_SEQ       1     14       Missing (in isoform Beta-1, isoform
FT                                Gamma-2 and isoform Gamma-3).
FT                                {ECO:0000303|PubMed:10684930}.
FT                                /FTId=VSP_010548.
FT   VAR_SEQ      53     63       Missing (in isoform Alpha-3 and isoform
FT                                Gamma-3). {ECO:0000303|PubMed:10684930,
FT                                ECO:0000303|PubMed:15489334}.
FT                                /FTId=VSP_010550.
FT   VAR_SEQ      53     62       Missing (in isoform Alpha-2 and isoform
FT                                Gamma-2). {ECO:0000303|PubMed:10684930}.
FT                                /FTId=VSP_010549.
FT   VARIANT      22     22       V -> M (in dbSNP:rs3219484).
FT                                {ECO:0000269|PubMed:12606733,
FT                                ECO:0000269|Ref.4}.
FT                                /FTId=VAR_018872.
FT   VARIANT     125    125       Y -> H (in FAP2).
FT                                {ECO:0000269|PubMed:15366000}.
FT                                /FTId=VAR_026045.
FT   VARIANT     128    128       W -> R (in FAP2).
FT                                {ECO:0000269|PubMed:12853198}.
FT                                /FTId=VAR_026046.
FT   VARIANT     148    148       G -> IW (in FAP2; dysfunctional in base
FT                                excision repair assay).
FT                                /FTId=VAR_064938.
FT   VARIANT     176    176       Y -> C (in FAP2; dysfunctional in base
FT                                excision repair assay; dbSNP:rs34612342).
FT                                {ECO:0000269|PubMed:11818965,
FT                                ECO:0000269|PubMed:12606733,
FT                                ECO:0000269|PubMed:12853198,
FT                                ECO:0000269|PubMed:18091433,
FT                                ECO:0000269|PubMed:19953527}.
FT                                /FTId=VAR_018873.
FT   VARIANT     179    179       R -> C (in FAP2).
FT                                {ECO:0000269|PubMed:18091433}.
FT                                /FTId=VAR_064939.
FT   VARIANT     179    179       R -> H (in FAP2).
FT                                {ECO:0000269|PubMed:15366000}.
FT                                /FTId=VAR_026047.
FT   VARIANT     182    182       R -> W (in FAP2; dysfunctional in base
FT                                excision repair assay).
FT                                {ECO:0000269|PubMed:18091433,
FT                                ECO:0000269|PubMed:19953527}.
FT                                /FTId=VAR_064940.
FT   VARIANT     238    238       R -> W (in FAP2; dbSNP:rs34126013).
FT                                {ECO:0000269|PubMed:15366000}.
FT                                /FTId=VAR_026048.
FT   VARIANT     335    335       Q -> H (in dbSNP:rs3219489).
FT                                {ECO:0000269|PubMed:12606733,
FT                                ECO:0000269|Ref.4}.
FT                                /FTId=VAR_018874.
FT   VARIANT     370    370       A -> V (in dbSNP:rs35352891).
FT                                /FTId=VAR_048262.
FT   VARIANT     393    393       G -> D (in FAP2; shows a glycosylase
FT                                activity very similar to the wild-type
FT                                protein; dbSNP:rs36053993).
FT                                {ECO:0000269|PubMed:11818965,
FT                                ECO:0000269|PubMed:12606733,
FT                                ECO:0000269|PubMed:12853198,
FT                                ECO:0000269|PubMed:18091433,
FT                                ECO:0000269|PubMed:19953527}.
FT                                /FTId=VAR_018875.
FT   VARIANT     402    402       P -> S (in GASC; sporadic).
FT                                {ECO:0000269|PubMed:15273732}.
FT                                /FTId=VAR_026049.
FT   VARIANT     411    411       Q -> R (in GASC; sporadic).
FT                                {ECO:0000269|PubMed:15273732}.
FT                                /FTId=VAR_026050.
FT   VARIANT     477    477       Missing (in FAP2; dysfunctional in base
FT                                excision repair assay).
FT                                /FTId=VAR_064941.
FT   VARIANT     500    500       G -> E (in dbSNP:rs3219494).
FT                                {ECO:0000269|Ref.4}.
FT                                /FTId=VAR_018876.
FT   VARIANT     512    512       S -> F (in dbSNP:rs140118273).
FT                                {ECO:0000269|PubMed:12606733}.
FT                                /FTId=VAR_026051.
FT   VARIANT     526    526       L -> M (in dbSNP:rs3219496).
FT                                {ECO:0000269|Ref.4}.
FT                                /FTId=VAR_018877.
FT   VARIANT     531    531       R -> Q (in dbSNP:rs3219497).
FT                                {ECO:0000269|Ref.4}.
FT                                /FTId=VAR_018878.
FT   HELIX        87    104       {ECO:0000244|PDB:3N5N}.
FT   HELIX       109    116       {ECO:0000244|PDB:3N5N}.
FT   HELIX       120    135       {ECO:0000244|PDB:3N5N}.
FT   HELIX       139    152       {ECO:0000244|PDB:3N5N}.
FT   HELIX       156    160       {ECO:0000244|PDB:3N5N}.
FT   HELIX       164    171       {ECO:0000244|PDB:3N5N}.
FT   HELIX       177    193       {ECO:0000244|PDB:3N5N}.
FT   HELIX       202    208       {ECO:0000244|PDB:3N5N}.
FT   HELIX       214    224       {ECO:0000244|PDB:3N5N}.
FT   HELIX       234    243       {ECO:0000244|PDB:3N5N}.
FT   HELIX       253    266       {ECO:0000244|PDB:3N5N}.
FT   HELIX       272    285       {ECO:0000244|PDB:3N5N}.
FT   STRAND      289    291       {ECO:0000244|PDB:3N5N}.
FT   HELIX       300    302       {ECO:0000244|PDB:3N5N}.
FT   HELIX       304    316       {ECO:0000244|PDB:3N5N}.
FT   HELIX       330    332       {ECO:0000244|PDB:3N5N}.
FT   STRAND      358    360       {ECO:0000244|PDB:1X51}.
FT   STRAND      366    377       {ECO:0000244|PDB:1X51}.
FT   STRAND      379    388       {ECO:0000244|PDB:1X51}.
FT   STRAND      403    405       {ECO:0000244|PDB:1X51}.
FT   HELIX       410    424       {ECO:0000244|PDB:1X51}.
FT   STRAND      447    456       {ECO:0000244|PDB:1X51}.
FT   STRAND      470    474       {ECO:0000244|PDB:1X51}.
FT   HELIX       475    480       {ECO:0000244|PDB:1X51}.
FT   HELIX       485    495       {ECO:0000244|PDB:1X51}.
SQ   SEQUENCE   546 AA;  60069 MW;  6C79BDB34345DD10 CRC64;
     MTPLVSRLSR LWAIMRKPRA AVGSGHRKQA ASQEGRQKHA KNNSQAKPSA CDGMIAECPG
     APAGLARQPE EVVLQASVSS YHLFRDVAEV TAFRGSLLSW YDQEKRDLPW RRRAEDEMDL
     DRRAYAVWVS EVMLQQTQVA TVINYYTGWM QKWPTLQDLA SASLEEVNQL WAGLGYYSRG
     RRLQEGARKV VEELGGHMPR TAETLQQLLP GVGRYTAGAI ASIAFGQATG VVDGNVARVL
     CRVRAIGADP SSTLVSQQLW GLAQQLVDPA RPGDFNQAAM ELGATVCTPQ RPLCSQCPVE
     SLCRARQRVE QEQLLASGSL SGSPDVEECA PNTGQCHLCL PPSEPWDQTL GVVNFPRKAS
     RKPPREESSA TCVLEQPGAL GAQILLVQRP NSGLLAGLWE FPSVTWEPSE QLQRKALLQE
     LQRWAGPLPA THLRHLGEVV HTFSHIKLTY QVYGLALEGQ TPVTTVPPGA RWLTQEEFHT
     AAVSTAMKKV FRVYQGQQPG TCMGSKRSQV SSPCSRKKPR MGQQVLDNFF RSHISTDAHS
     LNSAAQ
//
